About the Authors, ix
Foreword, xi
List of Abbreviations, xiii
Section A: Basic concepts
A.1 How to use this book, 3
A.2 Basic concepts in the epidemiology and control of infectious diseases,
4
A.3 Basic concepts in the prevention of infection, 9
A.4 Emergency risk communication, 13
A.5 Health protection on call, 15
Section B: Syndromes
B.1 Meningitis and meningism, 23
B.2 Gastrointestinal infection, 26
B.3 Community-acquired pneumonia, 32
B.4 Rash in pregnancy, 35
B.5 Rash and fever in children, 36
B.6 Illness in returning travellers, 38
B.7 Jaundice, 40
B.8 Infection in the immunocompromised, 41
Section C: Diseases
C.1 Amoebic dysentery, 47
C.2 Anthrax, 48
C.3 Bacillus cereus, 51
C.4 Botulism, 52
C.5 Brucellosis, 56
C.6 Campylobacter, 58
C.7 Chickenpox and shingles (varicella zoster infections), 62
C.8 Chikungunya, 64
C.9 Chlamydophila pneumoniae, 66
C.10 Chlamydia trachomatis, 67
C.11 Cholera, 69
C.12 CJD and other human transmissible spongiform encephalopathies, 71
C.13 Clostridioides difficile, 74
C.14 Clostridium perfringens, 76
C.15 Coronavirus (excluding COVID-19), 78
C.16 COVID-19, 81
C.17 Cryptosporidiosis, 84
C.18 Cyclosporiasis, 88
C.19 Cytomegalovirus, 89
C.20 Dengue fever, 91
C.21 Diphtheria, 92
C.22 Enterococci, including glycopeptide-resistant enterococci, 95
C.23 Enterovirus infections (including hand, foot and mouth disease), 96
C.24 Epstein-Barr virus, 98
C.25 Giardiasis, 100
C.26 Gram-negative bacteraemia (including carbapenem-resistant
enterobacterales), 102
C.27 Gonorrhoea, syphilis and other acute STIs, 107
C.28 Hantavirus, 113
C.29 Head lice, 114
C.30 Helicobacter pylori, 116
C.31 Hepatitis A, 117
C.32 Hepatitis B, 120
C.33 Hepatitis C, 123
C.34 Delta hepatitis, 125
C.35 Hepatitis E, 126
C.36 Herpes simplex, 127
C.37 Haemophilus influenzae type b (Hib), 129
C.38 HIV and AIDS, 131
C.39 Influenza, 136
C.40 Japanese B encephalitis, 141
C.41 Legionellosis, 141
C.42 Leprosy, 145
C.43 Leptospirosis, 146
C.44 Listeriosis, 148
C.45 Lyme disease (borreliosis), 150
C.46 Malaria, 152
C.47 Measles, 154
C.48 Meningococcal infection, 156
C.49 Meticillin-resistant Staphylococcus aureus (MRSA), 160
C.50 Mumps, 163
C.51 Mycoplasma pneumoniae, 165
C.52 Norovirus, 166
C.53 Paratyphoid fever, 169
C.54 Parvovirus B19 (fifth disease), 172
C.55 Plague, 173
C.56 Pneumococcal infection, 175
C.57 Poliomyelitis, 178
C.58 Psittacosis, 180
C.59 Q fever, 182
C.60 Rabies, 184
C.61 Relapsing Fever, 186
C.62 Respiratory Syncytial Virus (RSV), 187
C.63 Ringworm, 189
C.64 Rotavirus, 193
C.65 Rubella, 194
C.66 Salmonellosis, 196
C.67 Scabies, 199
C.68 Schistosomiasis, 202
C.69 Shigellosis, 204
C.70 Shiga Toxin-Producing Escherichia coli (STEC) and Other Diarrhoeagenic
E. coli, 207
C.71 Smallpox and mpox, 212
C.72 Staphylococcal food poisoning, 217
C.73 Streptococcal infections, 218
C.74 Tetanus, 220
C.75 Threadworms, 222
C.76 Tickborne encephalitis, 223
C.77 Toxocariasis, 224
C.78 Toxoplasmosis, 225
C.79 Tuberculosis (and non-tuberculous mycobacteria), 227
C.80 Tularaemia, 235
C.81 Typhoid fever, 237
C.82 Vibrio parahaemolyticus infection, 239
C.83 Viral haemorrhagic fevers, including Ebola, 241
C.84 Warts and verrucae, 244
C.85 West Nile virus, 246
C.86 Whooping cough, 247
C.87 Yellow fever, 250
C.88 Yersiniosis, 251
C.89 Zika virus infection, 253
C.90 Rare diseases, 256
C.90.1 Bacteria, 256
C.90.2 Rickettsial infections (incl. Typhus) Ehrlichia and Bartonella, 256
C.90.3 Viruses, 263
C.90.4 Protozoa, 263
C.90.5 Helminths, 263
C.90.6 Fungi and actinomycetes, 271
C.90.7 Bites, stings and venoms, 282
C.90.8 Chemical foodborne illness, 283
Section D: Health protection services and functions
D.1 Surveillance of communicable disease, 287
D.2 Managing infectious disease incidents and outbreaks, 293
D.3 Community infection control, 299
D.4 Hospital infection control, 304
D.5 Antimicrobial stewardship, 309
D.6 Risks to and from healthcare workers, 312
D.7 Immunisation services, 316
D.8 Coordination of sexual health services, 320
D.9 Prevention of bloodborne viral infections, 322
D.10 Coordination of services for tuberculosis control, 326
D.11 Travel health, 328
D.12 Migrant and refugee health, 331
D.13 Emergency preparedness planning and response, 334
D.14 Non-infectious environmental hazards, 336
D.15 Managing acute chemical incidents, 342
D.16 Managing acute radiation incidents, 345
D.17 Deliberate release of biological, chemical or radiological hazards,
348
D.18 Clinical governance and audit, 356
D.19 Global health security, 359
Section E: Organizational arrangements
E.1 WHO and International Health Regulations, 365
E.2 Collaboration within the European Union, 367
E.3 Detailed national example: Organisational arrangements for health
protection, England, 2025, 369
E.4 Austria, 374
E.5 Belgium, 375
E.6 Bulgaria, 375
E.7 Croatia, 376
E.8 Cyprus, 377
E.9 Czech Republic, 377
E.10 Denmark, 378
E.11 Estonia, 379
E.12 Finland, 379
E.13 France, 380
E.14 Germany, 381
E.15 Greece, 382
E.16 Hungary, 382
E.17 Iceland, 383
E.18 Ireland, 384
E.19 Italy, 385
E.20 Latvia, 385
E.21 Lithuania, 386
E.22 Luxembourg, 387
E.23 Malta, 388
E.24 The Netherlands, 388
E.25 Norway, 389
E.26 Poland, 390
E.27 Portugal, 391
E.28 Romania, 391
E.29 Slovakia, 392
E.30 Slovenia, 393
E.31 Spain, 394
E.32 Sweden, 395
E.33 Switzerland, 395
E.34 United Kingdom, 396
Index, 399